Macrolide Antibiotics Market Size Worth USD 7.0 billion by 2032 at 2.3% CAGR, Says AMR

Allied Market Research published a report, titled, "Macrolide Antibiotics Market By Drug Type (Azithromycin, Erythromycin, Others), By Route Of Administration (Oral, Parenteral, Others), By Indication (Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers): Global Opportunity Analysis And Industry Forecast, 2023-2032′′. The global macrolide antibiotics market was valued at $5.6 billion in 2022 and is projected to reach $7.0 billion by 2032, registering a CAGR of 2.3% from 2023 to 2032.

Macrolides represent a class of antibiotics characterized by their macrocyclic lactone structure, to which one or more deoxy sugars are attached. These antibiotics function by irreversibly binding to a specific location on the 50S subunit of the bacterial ribosome, thereby inhibiting the translocation phase of protein synthesis. While they are typically considered bacteriostatic, at higher doses, they can exhibit bactericidal properties. Macrolide antibiotics are commonly prescribed for the treatment of various respiratory tract infections, including pneumonia, bronchitis, sinusitis, pharyngitis, as well as for managing sexually transmitted infections like chlamydia, gonorrhea, and others.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/70066

What are the Recent Trends in the Macrolide Antibiotics Market?

The global macrolide antibiotics market is expanding rapidly due to factors such as a rise in incidences of bacterial infections, availability of generic medications and significant demand for macrolides from emerging countries. However, a surge in antimicrobial resistance and side effects associated with macrolide antibiotics hinder the market growth to some extent. Nevertheless, rise in investments in research and development activities will provide ample growth opportunities in the upcoming future.

Top Macrolide Antibiotics Companies

• Abbott Laboratories
• Pfizer Inc.
• Alkem Laboratories Ltd.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Limited
• Wellona Pharma Private Limited.
• Bristol Laboratories Ltd.
• Crescent Pharma Limited
• Merck And Co., Inc.
• Zydus Lifesciences Limited

Macrolide Antibiotics Market segmentation can be done based on several factors, including:

Based on drug type, the Azithromycin segment held the highest market share in 2022, accounting for nearly two-thirds of the global macrolide antibiotics market revenue and is projected to rule the roost throughout the forecast timeframe. The key drivers for the growth of azithromycin segment includes the widespread availability of azithromycin in both branded and generic forms. On the other hand, the others segment is anticipated to showcase the highest CAGR of 2.8% during the forecast period. This is attributed to the surge in incidences of bacterial infections around the globe, and effectives of macrolide antibiotics in treatment of severe bacterial infections.

Based on route of administration, the oral segment accounted for the largest share in 2022, accounting for nearly three-fourths of the global macrolide antibiotics market revenue and is anticipated to retain its dominance during the forecast period. The oral macrolide antibiotics segment is mainly boosted, owing to the availability of wide range of generic versions, which increases its adoption, and propels the market growth. The same segment would display the highest CAGR of 2.5% during the forecast period.

Based on indication, the respiratory tract infections segment accounted for the largest share in 2022, accounting for nearly two-fifths of the global macrolide antibiotics market revenue and is estimated to grab the lion's share during the forecast period. Rise in prevalence of respiratory tract infections leads to increase in demand for macrolide antibiotics for its treatment, which propels the segment growth. The same segment is expected to manifest a notable CAGR of 2.8% from 2023 to 2032.

Based on distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2022, accounting for more than half of the global market and is expected to maintain its dominance during the forecast period. This growth is attributed to the availability of a wide range of antibiotics to meet the needs of consumers. On the other hand, the online providers segment is anticipated to display the fastest CAGR of 3.1% during the forecast period, owing to numerous advantages such as quick accessibility and convenience.

Based on region, Asia-Pacific held the highest market share of more than one-third of the global macrolide antibiotics market in 2022 and is projected to maintain its dominance during the forecast period. This is attributed to the large population base in countries such as China and India, rising healthcare expenditure, and developing healthcare infrastructure. The same region would display the fastest CAGR of 2.8% from 2023 to 2032.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/70066

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
Which region has more opportunities?
By Region Outlook

North America
(U.S., Canada, Mexico)
Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.